Subchondroplasty for Treatment of Bone Marrow Edema in the Foot and Ankle

NCT03921489 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-05-04

No results posted yet for this study

Summary

The subchondroplasty procedure has been used to treat bone marrow edema mostly located in the periarticular region of the knee. In the past few years, it has expanded its use in the foot and ankle. There has, however, been very minimal research documented on its utilization in that area. This study aims to prospectively evaluate the course of treatment and outcomes of painful bone marrow lesions in these associated podiatric circumstances using subchondroplasty. It is hypothesized that use of calcium phosphate bone substitute in the foot and ankle to treat bone marrow edema will have more favorable short and long-term outcomes than joint destructive and joint sparing procedures more commonly performed for treatment in the past.

Conditions

  • Bone Marrow Edema

Interventions

PROCEDURE

Subchondroplasty

Calcium phosphate mineral compound injected into the bone marrow lesions

Sponsors & Collaborators

  • Ellianne M. Nasser

    lead OTHER

Principal Investigators

  • Ellianne Nasser, MD · Geisinger Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-04
Primary Completion
2024-12-19
Completion
2024-12-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03921489 on ClinicalTrials.gov